Sorry, but it is completely incorrect to state, and continue to state, that market cap is all that matters. The laws of supply and demand apply to all commodities, even equity shares. There is so much opportunity to flip shares here, and we have seen it throughout the history of this company. The recent run to .005 is a classic example, proving the point that escalating prices are not sustainable with this structure. Flippers rode it up, and dumped quickly for quick profits. EASY to do with billions available and high volume days driven by little news.
IF BIEL ever becomes profitable (that that is a rather large IF), that will drive the PPS upwards, until flippers again dump for immediate profits. After fourteen years of failure, most will not be willing to hang around waiting for sustained gains, OR the CEO promised R/S on profitability. THAT IS FROM THE CEO HIMSELF! An R/S will damage anyone holing long, and flippers won't wait around for that debacle.
As for Merck and J&J - what do you think predictions of 'billions coming for BIEL' are, if not grandiose pipe dreams of BIEL becoming a major powerhouse. Ludicrous, of course, but clearly some think BIEL will be a big time player.
Especially hilarious given the mom and pop way this operation is run. No understanding of manufacturing principles. Studies announced with minimal participants, and even those don't get off the ground. Family run and family operated - right into the ground.
Market Data 
Markets 
